The Bangladesh Medical Research Council (BMRC) has taken a policy decision on the COVID vaccine trial of Globe Biotech subject to conditions.
The Bangladesh Medical Research Council (BMRC) announced the decision at noon on Wednesday (June 16).
As part of the clinical trial of Globe Biotech’s vaccine, the drug administration received permission to produce the vaccine on December 28 last year. A letter was sent to BMRC on February 17 this year seeking that approval.
Earlier, on October 18 last year, the World Health Organization included three vaccines developed by Globe Biotech in the list of pre-clinical candidates.
